Ferroxidase activity of apoferritin is increased in the presence of platinum nanoparticles

Ferritin nanocages: a versatile platform for nanozyme design

Nanozymes are a class of nanomaterials with enzyme-like activities and have attracted increasing attention due to their potential applications in biomedicine. However, nanozyme design incorporating the desired properties remains challenging. Natural or genetically engineered protein scaffolds, such as ferritin nanocages, have emerged as a promising platform for nanozyme design due to their unique protein structure, natural biomineralization capacity, self-assembly properties, and high biocompatibility. In this review, we highlight the intrinsic properties of ferritin nanocages, especially for nanozyme design. We also discuss the advantages of genetically engineered ferritin in the versatile design of nanozymes over natural ferritin. Additionally, we summarize the bioapplications of ferritin-based nanozymes based on their enzyme-mimicking activities. In this perspective, we mainly provide potential insights into the utilization of ferritin nanocages for nanozyme design.

Apoferritin and Apoferritin-Capped Metal Nanoparticles Inhibit Arginine Kinase of Trypanosoma brucei

The aim of this study was to explore the inhibitory potential of apoferritin or apoferritin-capped metal nanoparticles (silver, gold and platinum) against Trypanosomabrucei arginine kinase. The arginine kinase activity was determined in the presence and absence of apoferritin or apoferritin-capped metal nanoparticles. In addition, kinetic parameters and relative inhibition of enzyme activity were estimated. Apoferritin or apoferritin-capped metal nanoparticles’ interaction with arginine kinase of T. brucei led to a >70% reduction in the enzyme activity. Further analysis to determine kinetic parameters suggests a mixed inhibition by apoferritin or apoferritin-nanoparticles, with a decrease in V_max. Furthermore, the K_m of the enzyme increased for both ATP and L-arginine substrates. Meantime, the inhibition constant (K_i) values for the apoferritin and apoferritin-nanoparticle interaction were in the submicromolar concentration ranging between 0.062 to 0.168 nM and 0.001 to 0.057 nM, respectively, for both substrates (i.e., L-arginine and ATP). Further kinetic analyses are warranted to aid the development of these nanoparticles as selective therapeutics. Also, more studies are required to elucidate the binding properties of these nanoparticles to arginine kinase of T. brucei.

Ferritins as natural and artificial nanozymes for theranostics

Nanozymes are a class of nanomaterials with intrinsic enzyme-like characteristics which overcome the limitations of natural enzymes such as high cost, low stability and difficulty to large scale preparation. Nanozymes combine the advantages of chemical catalysts and natural enzymes together, and have exhibited great potential in biomedical applications. However, the size controllable synthesis and targeting modifications of nanozymes are still challenging. Here, we introduce ferritin nanozymes to solve these problems. Ferritins are natural nanozymes which exhibit intrinsic enzyme-like activities (e.g. ferroxidase, peroxidase). In addition, by biomimetically synthesizing nanozymes inside the ferritin protein shells, artificial ferritin nanozymes are introduced, which possess the advantages of versatile self-assembly ferritin nanocage and enzymatic activity of nanozymes. Ferritin nanozymes provide a new horizon for the development of nanozyme in disease targeted theranostics research. The emergence of ferritin nanozyme also inspires us to learn from the natural nanostructures to optimize or rationally design nanozymes. In this review, the intrinsic enzyme-like activities of ferritin and bioengineered synthesis of ferritin nanozyme were summarized. After that, the applications of ferritin nanozymes were covered. Finally, the advantages, challenges and future research directions of advanced ferritin nanozymes for biomedical research were discussed.

Preparation of platinum nanoparticles using iron(ii) as reductant and photosensitized H2 generation on an iron storage protein scaffold

The quest for efficient solar-to-fuel conversion has led to the development of numerous homogeneous and heterogeneous systems for photochemical stimulation of 2H⁺ + 2e⁻ → H₂. Many such systems consist of a photosensitizer, an H₂-evolving catalyst (HEC), and sacrificial electron donor often with an electron relay between photosensitizer and HEC. Colloidal platinum remains a popular HEC. We report here a novel, simple, and high yield synthesis of Pt nanoparticles (Pt NPs) associated with human heavy chain ferritin (Hfn). The formation of the Pt NPs capitalizes on Hfn's native catalysis of autoxidation of Fe(ii)(aq) (ferroxidase activity). Fe(ii) reduces Pt(ii) to Pt(0) and the rapid ferroxidase reaction produces FeO(OH), which associates with and stabilizes the incipient Pt NPs. This Pt/Fe-Hfn efficiently catalyzes photosensitized H₂ production when combined with Eosin Y (EY) as photosensitizer and triethanolamine (TEOA) as sacrificial electron donor. With white light irradiation turnover numbers of 300H₂ per Pt, 250H₂ per EY were achieved. A quantum yield of 18% for H₂ production was obtained with 550 nm irradiation. The fluorescence emission of EY is quenched by TEOA but not by Pt/Fe-Hfn. We propose that the photosensitized H₂ production from aqueous TEOA, EY, Pt/Fe-Hfn solution occurs via a reductive quenching pathway in which both the singlet and triplet excited states of EY are reduced by TEOA to the anion radical, EY⁻˙, which in turn transfers electrons to the Pt/Fe-Hfn HEC. Hfn is known to be a remarkably versatile scaffold for incorporation and stabilization of noble metal and semiconductor nanoparticles. Since both EY and Hfn are amenable to scale-up, we envision further refinements to and applications of this photosensitized H₂-generating system.

An assembly of platinum nanoparticles produced by Fe(ii) reduction of Pt(ii) and stabilized by human heavy chain ferritin's native catalysis of Fe(ii)(aq) autoxidation functions as an efficient photosensitized H₂ evolution catalyst.

Encapsulation as a Strategy for the Design of Biological Compartmentalization

Compartmentalization is one of the defining features of life. Through intracellular spatial control, cells are able to organize and regulate their metabolism. One of the most broadly used organizational principles in nature is encapsulation. Cellular processes can be encapsulated within either membrane-bound organelles or proteinaceous compartments that create distinct microenvironments optimized for a given task. Further challenges addressed through intracellular compartmentalization are toxic or volatile pathway intermediates, slow turnover rates and competing side reactions. This review highlights a selection of naturally occurring membrane- and protein-based encapsulation systems in microbes and their recent applications and emerging opportunities in synthetic biology. We focus on examples that use engineered cellular organization to control metabolic pathway flux for the production of useful compounds and materials.

Lysozyme-directed synthesis of platinum nanoclusters as a mimic oxidase

We present a simple, one-pot approach for synthesizing ultrafine platinum (Pt) nanoclusters (NCs) under alkaline conditions using lysozyme (Lys) as a template. From the analysis of the nanoclusters by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Lys VI-stabilized Pt NCs majorly consisted of Pt4 clusters. The formation of Pt NCs was confirmed using X-ray photoelectron spectroscopy and Fourier-transformed infrared spectroscopy. The maximal fluorescence of Pt NCs appears at 434 nm with a quantum yield of 0.08, a fluorescence lifetime of 3.0 ns, and excitation-dependent emission wavelength behavior. Pt NCs exhibit an intrinsic oxidase-like activity because Pt NCs can catalyze O2 oxidation of organic substrates through a four-electron reduction process. Compared with larger Pt nanoparticles, the Pt NCs produce substantially greater catalytic activity in the O2-mediated oxidation of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid), 3,3',5,5'-tetramethylbenzidine, and dopamine.

Interaction of metal nanoparticles with recombinant arginine kinase from Trypanosoma brucei: thermodynamic and spectrofluorimetric evaluation

BACKGROUND

Trypanosoma brucei, responsible for African sleeping sickness, is a lethal parasite against which there is need for new drug protocols. It is therefore relevant to attack possible biomedical targets with specific preparations and since arginine kinase does not occur in humans but is present in the parasite it becomes a suitable target.

METHODS

Fluorescence quenching, thermodynamic analysis and FRET have shown that arginine kinase from T. brucei interacted with silver or gold nanoparticles.

RESULTS

The enzyme only had one binding site. At 25°C the dissociation (Kd) and Stern-Volmer constants (KSV) were 15.2nM, 0.058nM(-1) [Ag]; and 43.5nM, 0.052nM(-1) [Au] and these decreased to 11.2nM, 0.041nM(-1) [Ag]; and 24.2nM, 0.039nM(-1) [Au] at 30°C illustrating static quenching and the formation of a non-fluorescent fluorophore-nanoparticle complex. Silver nanoparticles bound to arginine kinase with greater affinity, enhanced fluorescence quenching and easier access to tryptophan molecules than gold. Negative ΔH and ΔG values implied that the interaction of both Ag and Au nanoparticles with arginine kinase was spontaneous with electrostatic forces. FRET confirmed that the nanoparticles were bound 2.11nm [Ag] and 2.26nm [Au] from a single surface tryptophan residue.

CONCLUSIONS

The nanoparticles bind close to the arginine substrate through a cysteine residue that controls the electrophilic and nucleophilic characters of the substrate arginine-guanidinium group crucial for enzymatic phosphoryl transfer between ADP and ATP.

GENERAL SIGNIFICANCE

The nanoparticles of silver and gold interact with arginine kinase from T. brucei and may prove to have far reaching consequences in clinical trials.

Multiple fold increase in activity of ferroxidase-apoferritin complex by silver and gold nanoparticles

The effect of silver (Ag) and gold (Au) nanoparticles on the ferroxidase activity of apoferritin showed a 110-fold increase in specific activity and a 9-fold increase over the control at the respective molar ratios of Au-apoferritin and Ag-apoferritin nanoparticles (NPs) of 500:1 and 1000:1. Typical color change, from pale yellow to brown, occurred when apoferritin was mixed with AgNO(3) or AuCl(3) followed by sodium borohydride to afford respective metal-apoferritin NP complexes in a ratio of between 250:1 and 4000:1. These complexes were characterized by ultraviolet-visible inductively coupled plasma-optical emission spectroscopy, Fourier transform infrared spectroscopy, transmission electron microscopy, and energy-dispersive x-ray spectroscopy. Transmission electron microscopy revealed that the size of NPs increased as the molar ratio of metal to apoferritin increased, with an average size of 3-6 nm generated with Au-to-apoferritin and/or Ag-to-apoferritin molar ratios of 250:1 to 4000:1. Fourier transform infrared spectrometry showed no structural changes of apoferritin when the NPs were attached to the protein.

FROM THE CLINICAL EDITOR

In this paper the utility of gold and silver nanoparticles in augmenting the activity of the ferroxidase-apoferritin complex is described. Both NPs dramatically increased the ferroxidase activity.